UNSPSC 85492046: Dilation of coronary artery, one site with drug-eluting intraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of coronary artery, one site with drug-eluting intraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 027044Z

UNSPSC 85492046 Dilation of coronary artery, one site with drug-eluting intraluminal device, percutaneous endoscopic approach is a Commodity code that describes a specific invasive cardiac procedure, but state and local procurement activity under this code does not match the procedure's clinical scope. The recent opportunities tagged to this code span occupational medical surveillance, independent disability medical evaluations, pharmacy benefit management, surgical carve-out networks, temporary health professional staffing, and emergency medical services for youth in custody — none of which involve coronary artery dilation or drug-eluting stents. The mismatch suggests misclassification or broad tagging of medical services categories by issuing offices rather than precise commodity-level procurement of this specific intervention.

Recent activity appears across Arizona, California, Florida, and Washington, with issuing bodies including city retirement offices (City of Phoenix), municipal human resources departments (City of Long Beach), county boards of commissioners (Collier County), state transportation agencies (Washington State Department of Transportation), county health systems (Santa Clara, Harris County), and county probation departments. The City of Phoenix Retirement Office solicited independent medical evaluation services (RFP RTMRFP26001, due October 16, 2026, maximum contract value $750,000 over five years); the Washington State Department of Transportation solicited occupational medical surveillance services across 14 ferry locations (RFP RFP20260825, due October 9, 2026); and Collier County solicited pharmacy benefit management services covering approximately 2,400 employees with historical annual spending of $8.7 million (RFP 258414, originally due April 9, 2026). Given the procedural-code classification and the absence of actual coronary intervention procurement, this code shows little substantive activity relevant to cardiac device or intervention vendors and should not be relied upon for market-sizing or pursue decisions in interventional cardiology.